scholarly article | Q13442814 |
P50 | author | Takashi Yoshiura | Q88110055 |
Kousei Ishigami | Q88561938 | ||
Yoshiki Asayama | Q88575700 | ||
H Honda | Q88632968 | ||
Akihiro Nishie | Q89914901 | ||
Nobuhiro Fujita | Q91958797 | ||
Shinichi Aishima | Q91965681 | ||
Yasuhiro Ushijima | Q102145028 | ||
Ken Shirabe | Q114433176 | ||
Yukihisa Takayama | Q114440705 | ||
Yuichiro Kubo | Q117226366 | ||
P2860 | cites work | Potential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors | Q30889007 |
Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths | Q31011793 | ||
Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings | Q33967898 | ||
1.5 tesla magnetic resonance imaging scanners compared with 3.0 tesla magnetic resonance imaging scanners: systematic review of clinical effectiveness | Q36234974 | ||
Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma | Q36320113 | ||
Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings | Q37354633 | ||
Consensus report of the 2nd International Forum for Liver MRI. | Q37620213 | ||
Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. | Q37766703 | ||
Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. | Q38026533 | ||
Cholangiocarcinoma: delayed CT contrast enhancement patterns | Q41448248 | ||
"Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor | Q43236786 | ||
Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats | Q46213238 | ||
Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production. | Q50533500 | ||
Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system | Q53026443 | ||
Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation. | Q53445917 | ||
Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma | Q67487811 | ||
The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan | Q69507027 | ||
CT of hepatic masses: significance of prolonged and delayed enhancement | Q70131505 | ||
MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation | Q73927764 | ||
Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans | Q74203499 | ||
The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology | Q77953205 | ||
Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique | Q81499168 | ||
The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging | Q84230646 | ||
Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma | Q84554967 | ||
Hepatic Hemangioma and Metastasis: Differentiation With Gadoxetate Disodium–Enhanced 3-T MRI | Q85063116 | ||
P433 | issue | 2 | |
P921 | main subject | intrahepatic cholangiocarcinoma | Q18556554 |
cholangiocarcinoma | Q124292 | ||
hepatocellular carcinoma | Q1148337 | ||
P304 | page(s) | 96-104 | |
P577 | publication date | 2015-03-01 | |
P1433 | published in | Diagnostic and interventional radiology : official journal of the Turkish Society of Radiology | Q26842393 |
P1476 | title | Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI | |
P478 | volume | 21 |
Q39259950 | Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma. |
Q38684422 | Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI. |
Q52982866 | Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings. |
Q41074605 | Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis |
Q44796084 | LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma. |
Q28075361 | Recent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRI |
Search more.